New research reveals the shingles vaccine may cut vascular dementia risk by half, offering unexpected brain protection beyond ...
After applying a mercury-laced skin cream for months, a woman begins to experience alarming neurological symptoms. Doctors ...
Clinical remission rates were over 85% for both TREMFYA® maintenance doses at 96 weeks in both the Phase 3 GRAVITI and GALAXI studies TREMFYA® is the only ...
A young woman shares her emotional 15-year journey with hidradenitis suppurativa, chronic skin inflammation for which ...